CN101954051B - Traditional Chinese medicinal composition used for curing cerebral thrombosis - Google Patents

Traditional Chinese medicinal composition used for curing cerebral thrombosis Download PDF

Info

Publication number
CN101954051B
CN101954051B CN201010516778XA CN201010516778A CN101954051B CN 101954051 B CN101954051 B CN 101954051B CN 201010516778X A CN201010516778X A CN 201010516778XA CN 201010516778 A CN201010516778 A CN 201010516778A CN 101954051 B CN101954051 B CN 101954051B
Authority
CN
China
Prior art keywords
parts
radix
cerebral thrombosis
treatment
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201010516778XA
Other languages
Chinese (zh)
Other versions
CN101954051A (en
Inventor
张汉卿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201010516778XA priority Critical patent/CN101954051B/en
Publication of CN101954051A publication Critical patent/CN101954051A/en
Application granted granted Critical
Publication of CN101954051B publication Critical patent/CN101954051B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicinal composite used for curing cerebral thrombosis. Aiming at the pathogenesiss of cerebral thrombosis and based on the principle of symptomatic treatment, motherwort herb, the root of herbaceous peony, radix ophiopogonis, Achyranthes bidentata, curcuma aromatica, uncaria, astragalus root and the root of red-rooted salvia are selected to prepare a decoction; raw oyster, tortoise shell, garter snake, Chinese polyphaga are used to prepare capsules, and the decoction and the capsules are taken at the same time. Through the clinic experiments and observations, the composite has better curative effect, the total effective rate is 91.5%, the composite has no side effect, is safe and cheap and is suitable for clinical popularization and application.

Description

A kind of Chinese medicine composition for the treatment of cerebral thrombosis
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine composition for the treatment of cerebral thrombosis.
Background technology
Cerebral thrombosis is a serious harm the people of the world health, influences the cerebrovascular accident disease of the chronic progressive external of life-span and quality of life, because it has the sickness rate height, and the disability rate height, the relapse rate height, mortality rate height and complication be a kind of like this characteristics how.Because taking place, the patient of cerebral thrombosis mostly is middle-aged and elderly people, wherein the old people with 60-70 year is maximum, so in selection to the cerebral thrombosis medicine, be that doctor, patient and family members are very careful, because old people's Liver and kidney is to be unable to stand side effects of pharmaceutical drugs for a long time to its damage that causes, and this side effect is very obvious in Western medicine.So treatment cerebral thrombosis, the expert of 90% cardiovascular and cerebrovascular disease treatment aspect can advise that the patient is when using one to two kind of indispensable Western medicine, also must take the Chinese Traditional Medicines of the every function of a kind of energy comprehensive care cerebrovascular, play Synergistic treatment, reach the therapeutic effect of efficacy enhancing and toxicity reducing.Chinese medicine, especially through genuine drawing materials, the big compound recipe modern Chinese medicine that modern crafts are produced, because its drug effect is obvious, safety is good, the Drug resistance height, long-lasting remarkable advantages such as strong has become the effectively main medication of treatment of cerebral thrombus forming patient.But treat cerebral thrombosis Chinese medicine at present and have all that curative effect is slow, the unfavorable problem of therapeutic effect.
Summary of the invention
The Chinese medicine composition that the purpose of this invention is to provide a kind of more efficiently treatment cerebral thrombosis.
The objective of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment cerebral thrombosis is made up of following parts by weight of Chinese traditional medicine:
Herba Leonuri 10-15 branch, Radix Paeoniae Alba 10-15 branch, Radix Ophiopogonis 5-10 branch, Radix Achyranthis Bidentatae 5-10 branch, Radix Curcumae 5-10 branch, Ramulus Uncariae Cum Uncis 3-7 branch, Radix Astragali 3-7 branch, Radix Salviae Miltiorrhizae 10-15 branch, Concha Ostreae 3-5 branch, Carapax et Plastrum Testudinis 5-7 branch, Zaocys 3-5 branch, Eupolyphaga Seu Steleophaga 5-7 branch.
The consumption of Chinese medicine composition each component of the present invention proves that through a large amount of clinical practices the optimum amount of preferred each component is:
Herba Leonuri 13 minutes, the Radix Paeoniae Alba 13 minutes, 7 minutes Radix Ophiopogonis, Radix Achyranthis Bidentatae 7 minutes, Radix Curcumae 7 minutes, Ramulus Uncariae Cum Uncis 5 minutes, the Radix Astragali 5 minutes, Radix Salviae Miltiorrhizae 13 minutes, Concha Ostreae 4 minutes, Carapax et Plastrum Testudinis 6 minutes, Zaocys 4 minutes, Eupolyphaga Seu Steleophaga 6 minutes.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to make oral preparations, Concha Ostreae, Zaocys, Eupolyphaga Seu Steleophaga, Carapax et Plastrum Testudinis, and above medicine is ground into powder, sieves, and incapsulates; Herba Leonuri, the Radix Paeoniae Alba, Radix Ophiopogonis, Radix Achyranthis Bidentatae, Radix Curcumae, Ramulus Uncariae Cum Uncis, the Radix Astragali, Radix Salviae Miltiorrhizae, more than each medicine add water decoction and concentrate to adopt bottled.
In technical solution of the present invention, the Herba Leonuri silt of invigorating blood circulation, dispel; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant; Radix Ophiopogonis YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire; The Radix Achyranthis Bidentatae invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards; Radix Curcumae regulating qi to disperse stagnation, heart fire-clearing upset-relieving; Ramulus Uncariae Cum Uncis heat clearing away suppressing the hyperactive liver, arresting convulsion relieves dizziness, high fever, infantile convulsions, epilepsy, etc.; Radix Astragali invigorating QI to consolidate the body surface resistance, the diuresis poison holding, it is weak to be used for the deficiency of vital energy; The Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Concha Ostreae: tranquillization with heavy prescription, the YANG hyperactivity suppressing nourishing YIN, hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweating; Zaocys dispels the wind, collateral dredging, relieving convulsion; Eupolyphaga Seu Steleophaga removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; The Carapax et Plastrum Testudinis nourishing YIN for suppressing the hyperactive YANG, replenishing kidney and strengthening bone, the reinforcing the heart of nourishing blood, consolidating channel for hemostasis.
Clinical data
1, physical data: each 118 example of treatment group and matched group are my patient of institute stochastic sampling grouping.Male 70 examples are organized in treatment, women 48 examples; Maximum 78 years old age, minimal ages 42 years old, 56 years old mean age; The course of disease 4 hours to 10 days, average (2.76 ± 0.72) sky; Wherein with hypertension 60 examples, coronary heart disease 48 examples, hyperlipidemia 89 examples, diabetes 32 examples.Matched group 118 examples, male 72 examples, women 46 examples; Maximum 80 years old age, minimum 43 years old, 57 years old mean age; The course of disease 3.5 hours to 9 days, average (2.15 ± 0.63) sky; Hypertension 62 examples wherein, coronary heart disease 52 examples, hyperlipidemia 91 examples, diabetes 31 examples.Two groups in sex, age, symptom, sign and complication no significant difference (P>0.05), has comparability.
2, diagnostic criteria is drafted diagnostic criteria [1] by the 4th national cerebrovascular academic conference in October nineteen ninety-five, turns out to be cerebral thrombosis through head CT or MRI.
3, Therapeutic Method
Treatment group: in Primary Care, take Chinese medicine preparation of the present invention, promptly grind the capsule of making into powder by Concha Ostreae, Carapax et Plastrum Testudinis, Zaocys, Eupolyphaga Seu Steleophaga; Add water decoction by Herba Leonuri, the Radix Paeoniae Alba, Radix Ophiopogonis, Radix Achyranthis Bidentatae, Radix Curcumae, Ramulus Uncariae Cum Uncis, the Radix Astragali, each medicine of Radix Salviae Miltiorrhizae and concentrate, every bottled 100 milliliters, 100 milliliters of day clothes, divide the secondary clothes, 7 of the capsules of at every turn taking after mixing it with water, 15 days is a course of treatment, twice 3-5 days at interval course of treatment, add up curative effect after three courses of treatment.
Matched group; Take aspirin, piracetam on the basis of Primary Care, 15 days is a course of treatment, twice 3-5 days at interval course of treatment, adds up curative effect after three courses of treatment.
4, efficacy assessment standard
According to " clinical disease diagnosis is cured improvement " standard.1. cure substantially: consciousness recovery is normal, Myodynamia recovery IV~V level, and life can be taken care of oneself.2. produce effects: consciousness recovery is normal, and muscular strength improves more than the II level, and life is taken care of oneself substantially.3. take a turn for the better: consciousness recovery is normal, and muscular strength improves the II level, can't take care of oneself.4. invalid: treating last symptom does not have obvious improvement.
5, therapeutic outcome
Treatment group total effective rate 91.5%, obvious effective rate are 79.6%; Matched group total effective rate 74.6%, obvious effective rate are 54.2%.Learn by statistics and handle, the treatment group is than matched group (P<0.05), and two groups apparent side effect (seeing Table 1) all do not occur.
Table 1 treatment group and the contrast of matched group clinical efficacy
Observe in two groups of treatment clinical cardinal symptoms in front and back and the sign index, disturbance of consciousness, vision and disturbance of visual field, hemiparesis or bilateral quadriplegia, two groups of Comparison of therapeutic of speech disorder have significant difference (seeing Table two).
The table 2 liang clinical cardinal symptom of group, sign Comparison of therapeutic
Figure BSA00000314946400042
6, toxicity
In clinical observation treatment group 118 examples, 69 customary liver functions, blood routine examination, all no abnormal variation, illustrate use this medicine after whole body have no adverse reaction.
7, model case
Case one: Lee, woman, 61 years old, the worker of enterprise.Suffered from cerebral thrombosis in 2008, my institute's treatment is changeed, finding when coming to the large hospital treatment of too much institute in front and back in March, 2009: the unable inconvenient activity of left side upper and lower extremities, and hand-held crutch walking is very slow, and sitting down stands up needs my old man to assist babble in.Check patient's muscular strength IV level, 8 kilograms of grips, lower limb are pedaled 10 kilograms of power.Through the treatment of three courses of treatment, the homonymy muscular strength reaches the V level, and grip reaches 17 kilograms, and the power of pedaling reaches 42 kilograms, and it is clearer to speak, and rises and sits freely.
Case two: Wu: burst in 56 years old is spat out white foams, and mountain, left side lower limb lose after the movable function companion facial hemiparalysis provincial capital large hospital and are in hospital to leave hospital after failing to respond to any medical treatment in 15 days and go home the court's prescription on individual diagnosis over second day of leaving hospital.Check blood pressure 140-70 left side upper and lower extremities afunction, facial hemiparalysis, can out-of-bed activity after treating two courses of treatment, fully recover after treating three courses of treatment.
The specific embodiment
Embodiment one:
Get Concha Ostreae 40 grams, Carapax et Plastrum Testudinis 60 grams, Zaocys 40 grams, Eupolyphaga Seu Steleophaga 60 grams, above medicine is ground mixing into powder, incapsulates.
Get Herba Leonuri 130 gram, the Radix Paeoniae Alba 130 grams, Radix Ophiopogonis 70 gram, Radix Achyranthis Bidentatae 70 grams, Radix Curcumae 70 grams, Ramulus Uncariae Cum Uncis 50 grams, the Radix Astragali 50 grams, Radix Salviae Miltiorrhizae 130 grams, above Chinese medicine adds 3500 milliliters of decocts of water, and 600 milliliters of bottlings of simmer down to when taking, utilize medicinal liquid to take capsule.

Claims (2)

1. Chinese medicine composition for the treatment of cerebral thrombosis, it is characterized in that getting Herba Leonuri 10-15 part, Radix Paeoniae Alba 10-15 part, Radix Ophiopogonis 5-10 part, Radix Achyranthis Bidentatae 5-10 part, Radix Curcumae 5-10 part, Ramulus Uncariae Cum Uncis 3-7 part, Radix Astragali 3-7 part, Radix Salviae Miltiorrhizae 10-15 part add water decoction concentrate adopt bottled; Get Concha Ostreae 3-5 part, Carapax et Plastrum Testudinis 5-7 part, Zaocys 3-5 part, Eupolyphaga Seu Steleophaga 5-7 part and grind and do not sieve, incapsulate.
2. a kind of Chinese medicine composition for the treatment of cerebral thrombosis according to claim 1, it is characterized in that getting 13 parts of 13 parts of Herba Leonuris, 13 parts of the Radix Paeoniae Albas, 7 parts of Radix Ophiopogonis, 7 parts of Radix Achyranthis Bidentataes, 7 parts of Radix Curcumaes, 5 parts of Ramulus Uncariae Cum Uncis, 5 parts of the Radixs Astragali, Radix Salviae Miltiorrhizae add water decoction concentrate adopt bottled; Get 4 parts of Concha Ostreae, 6 parts of Carapax et Plastrum Testudiniss, 4 parts of Zaocyss, Eupolyphaga Seu Steleophaga and grind for 6 parts and do not sieve, incapsulate.
CN201010516778XA 2010-10-09 2010-10-09 Traditional Chinese medicinal composition used for curing cerebral thrombosis Expired - Fee Related CN101954051B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010516778XA CN101954051B (en) 2010-10-09 2010-10-09 Traditional Chinese medicinal composition used for curing cerebral thrombosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010516778XA CN101954051B (en) 2010-10-09 2010-10-09 Traditional Chinese medicinal composition used for curing cerebral thrombosis

Publications (2)

Publication Number Publication Date
CN101954051A CN101954051A (en) 2011-01-26
CN101954051B true CN101954051B (en) 2011-11-16

Family

ID=43481806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010516778XA Expired - Fee Related CN101954051B (en) 2010-10-09 2010-10-09 Traditional Chinese medicinal composition used for curing cerebral thrombosis

Country Status (1)

Country Link
CN (1) CN101954051B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336225A (en) * 2001-08-21 2002-02-20 徐凤玉 Cerebral thrombus treating traditional Chinese medicine
CN101357198A (en) * 2008-09-12 2009-02-04 康兆毅 Traditional Chinese medicine for treating cerebral thrombus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336225A (en) * 2001-08-21 2002-02-20 徐凤玉 Cerebral thrombus treating traditional Chinese medicine
CN101357198A (en) * 2008-09-12 2009-02-04 康兆毅 Traditional Chinese medicine for treating cerebral thrombus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
史连和等.《中医药治疗高血压病进展》.《内蒙古民族大学学报(自然科学版)》.2003,第18卷(第3期),277-282. *
周永红等.《中风后遗症证治近况》.《山东中医杂志》.2001,第20卷(第1期),58-61. *

Also Published As

Publication number Publication date
CN101954051A (en) 2011-01-26

Similar Documents

Publication Publication Date Title
CN101711847B (en) Oral traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
CN101890124A (en) Chinese medicinal health care product with blood fat reduction effect
CN101361945B (en) Traditional Chinese medicine preparation for treating cardio-cerebrovascular disease
CN102526276B (en) Anti-hypertension medicinal composition and preparation method for same
CN101584796B (en) Application of traditional Chinese medicine composition in preparing medicament for treating melancholia
CN102813764B (en) Chinese herbal medicinal composition used for reducing blood viscosity and blood lipid and preparation method thereof
CN101954051B (en) Traditional Chinese medicinal composition used for curing cerebral thrombosis
CN102836338A (en) Chinese medicament for treating cardia-cerebrovascular diseases
CN105477330A (en) Traditional Chinese medicine composition for treating arrhythmia
CN101703660B (en) Anti-aging medicament
CN101229360B (en) Anti-AIDS medicine
CN105106758A (en) Traditional Chinese medicine composition for treating phlegm and blood stasis type dizziness
CN102716293A (en) Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease
CN104623330A (en) Chinese medicinal composition for treating hyperlipidemia
CN103385963A (en) Chinese medicine preparation for treating angina pectoris caused by coronary heart disease
CN103520647B (en) A kind of adjustment hyperlipidemia Chinese medicine preparation
CN103285108B (en) Chinese medicinal composition treating lumbago
CN101559134A (en) Chinese materia medica preparation for treating rosacea
CN102805795B (en) Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof
CN102349983A (en) Traditional Chinese medicine composition for treating ischemic apoplexia
CN102526412A (en) Chinese medicine composition for treating myocardial infarction
CN102335203A (en) Miniature decoction
CN105687799A (en) Traditional Chinese medicine composition for treating epilepsy
CN104825917A (en) Traditional Chinese medicine preparation for weight reducing
CN104873896A (en) Traditional Chinese medicine composition for treating stroke caused by hypertension

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111116

Termination date: 20121009